VA
GRDN

Vident Advisory’s Guardian Pharmacy Services GRDN Stock Holding History

Vident Advisory’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$479K Buy
+12,709
New +$415K ﹤0.01% 1282

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vident Advisory's GRDN Position: Q1 2026 in Review

Vident Advisory opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 12,709 shares worth $479K. The stake represents ﹤0.01% of the portfolio and ranks #1282 among its holdings.

171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Vident Advisory held 12,709 shares of Guardian Pharmacy Services worth $479K as of Q1 2026.
  • Guardian Pharmacy Services was a new Vident Advisory position in Q1 2026.
  • Guardian Pharmacy Services made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1282 holding.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.